Pedro Araos

1.1k total citations
37 papers, 717 citations indexed

About

Pedro Araos is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry and Pathology and Forensic Medicine. According to data from OpenAlex, Pedro Araos has authored 37 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 12 papers in Biological Psychiatry and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Pedro Araos's work include Tryptophan and brain disorders (12 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Alcohol Consumption and Health Effects (10 papers). Pedro Araos is often cited by papers focused on Tryptophan and brain disorders (12 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Alcohol Consumption and Health Effects (10 papers). Pedro Araos collaborates with scholars based in Spain, Canada and United States. Pedro Araos's co-authors include Fernando Rodrı́guez de Fonseca, Francisco Javier Pavón, Antonia Serrano, Juan Suárez, Nuria García‐Marchena, Estela Castilla‐Ortega, María Pedraz, Luis J. Santín, Eduardo Blanco and Marta Torrens and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Pedro Araos

36 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedro Araos Spain 18 270 199 187 118 111 37 717
Nuria García‐Marchena Spain 15 182 0.7× 165 0.8× 146 0.8× 95 0.8× 99 0.9× 35 558
Michal Taler Israel 16 214 0.8× 255 1.3× 102 0.5× 203 1.7× 113 1.0× 37 835
María Pedraz Spain 15 152 0.6× 118 0.6× 89 0.5× 62 0.5× 73 0.7× 19 435
Lesa Dieter United States 13 284 1.1× 327 1.6× 148 0.8× 209 1.8× 119 1.1× 16 905
David Budac United States 14 146 0.5× 556 2.8× 221 1.2× 111 0.9× 143 1.3× 21 897
Gianluigi Guidotti Italy 10 194 0.7× 235 1.2× 63 0.3× 113 1.0× 70 0.6× 12 648
Hitoshi Maeshima Japan 20 116 0.4× 262 1.3× 119 0.6× 148 1.3× 70 0.6× 35 806
Antonio Noronha United States 10 266 1.0× 54 0.3× 55 0.3× 101 0.9× 107 1.0× 13 624
Joyonna Gamble‐George United States 14 511 1.9× 115 0.6× 562 3.0× 144 1.2× 83 0.7× 23 1.1k
Argel Aguilar‐Valles Canada 19 420 1.6× 268 1.3× 104 0.6× 254 2.2× 84 0.8× 31 1.2k

Countries citing papers authored by Pedro Araos

Since Specialization
Citations

This map shows the geographic impact of Pedro Araos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Araos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Araos more than expected).

Fields of papers citing papers by Pedro Araos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Araos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Araos. The network helps show where Pedro Araos may publish in the future.

Co-authorship network of co-authors of Pedro Araos

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Araos. A scholar is included among the top collaborators of Pedro Araos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Araos. Pedro Araos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Marchena, Nuria, Pedro Araos, Juan Jesús Ruiz, et al.. (2025). Exploratory study on plasma Acylglycerol and Acylethanolamide dysregulation in substance use and attention-deficit/hyperactivity disorder: Implications for novel biomarkers in dual diagnosis. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 138. 111350–111350.
2.
García‐Marchena, Nuria, Francisco Javier Pavón, Laura Sánchez‐Marín, et al.. (2023). Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders. Translational Psychiatry. 13(1). 215–215. 1 indexed citations
3.
Araos, Pedro, Nuria García‐Marchena, Juan Suárez, et al.. (2023). Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder. International Journal of Molecular Sciences. 24(11). 9371–9371. 1 indexed citations
4.
García‐Marchena, Nuria, Alberto Marcos, Mario G. Moreno, et al.. (2022). Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex. Biomedicines. 10(5). 1137–1137. 3 indexed citations
5.
Papaseit, Esther, Nuria García‐Marchena, Juan Jesús Ruiz, et al.. (2022). Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder. Biomedicines. 10(5). 947–947. 12 indexed citations
6.
García‐Marchena, Nuria, Pedro Araos, Juan Suárez, et al.. (2022). Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders. Brain Sciences. 12(5). 588–588. 4 indexed citations
7.
García‐Marchena, Nuria, Francisco Javier Pavón, Pedro Araos, et al.. (2021). Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease. Biomedicines. 9(9). 1207–1207. 6 indexed citations
8.
Araos, Pedro, Nuria García‐Marchena, Patricia Rivera, et al.. (2021). Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder. Scientific Reports. 11(1). 15583–15583. 14 indexed citations
9.
Romero‐Sanchiz, Pablo, Raquel Nogueira‐Arjona, Pedro Araos, et al.. (2020). Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy. Scientific Reports. 10(1). 1078–1078. 11 indexed citations
10.
García‐Marchena, Nuria, Nieves Pizarro, Francisco Javier Pavón, et al.. (2020). Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients. Scientific Reports. 10(1). 17163–17163. 11 indexed citations
11.
Vidal, Rebeca, Nuria García‐Marchena, Esther O’Shea, et al.. (2020). Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 102. 109958–109958. 19 indexed citations
12.
Romero‐Sanchiz, Pablo, Raquel Nogueira‐Arjona, Antoni Pastor, et al.. (2019). Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants. Neuropharmacology. 149. 212–220. 38 indexed citations
13.
Montesinos, Jorge, Estela Castilla‐Ortega, Laura Sánchez‐Marín, et al.. (2019). Cocaine-induced changes in CX3CL1 and inflammatory signaling pathways in the hippocampus: Association with IL1β. Neuropharmacology. 162. 107840–107840. 14 indexed citations
14.
García‐Marchena, Nuria, Joan Ignasi Mestre-Pintó, Pedro Araos, et al.. (2019). Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders. PLoS ONE. 14(3). e0213791–e0213791. 20 indexed citations
15.
García‐Marchena, Nuria, David Ladrón de Guevara‐Miranda, María Pedraz, et al.. (2018). Higher Impulsivity As a Distinctive Trait of Severe Cocaine Addiction among Individuals Treated for Cocaine or Alcohol Use Disorders. Frontiers in Psychiatry. 9. 26–26. 22 indexed citations
16.
García‐Marchena, Nuria, Ana Isabel Martı́n, María Ángeles Villanúa, et al.. (2017). Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders. PLoS ONE. 12(11). e0187634–e0187634. 34 indexed citations
17.
Pedraz, María, Ana Isabel Martı́n, Nuria García‐Marchena, et al.. (2015). Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders: Relationship to Psychiatric Comorbidity. PLoS ONE. 10(3). e0118610–e0118610. 26 indexed citations
18.
Pedraz, María, Pedro Araos, Antonia Serrano, et al.. (2015). Sex Differences in Psychiatric Comorbidity and Plasma Biomarkers for Cocaine Addiction in Abstinent Cocaine-Addicted Subjects in Outpatient Settings. Frontiers in Psychiatry. 6. 17–17. 37 indexed citations
19.
Araos, Pedro, Esperanza Vergara‐Moragues, María Pedraz, et al.. (2014). Comorbilidad psicopatológica en consumidores de cocaína en tratamiento ambulatorio. Adicciones. 26(1). 15–26. 27 indexed citations
20.
Orío, Laura, Francisco Javier Pavón, Eduardo Blanco, et al.. (2013). Lipid Transmitter Signaling as a New Target for Treatment of Cocaine Addiction: New Roles for Acylethanolamides and Lysophosphatidic Acid. Current Pharmaceutical Design. 19(40). 7036–7049. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026